SOR-C13 structure
|
Common Name | SOR-C13 | ||
|---|---|---|---|---|
| CAS Number | 1187852-48-7 | Molecular Weight | 1565.81 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C72H116N20O19 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SOR-C13SOR-C13, a carboxy-terminal truncated peptide, is a high-affinity TRPV6 antagonist with an IC50 value of 14 nM. TRPV6 is a non-voltage gated calcium channel that is associated with malignancy and poor prognosis in breast cancer. SOR-C13 has anticancer activity[1]. |
| Name | SOR-C13 |
|---|
| Description | SOR-C13, a carboxy-terminal truncated peptide, is a high-affinity TRPV6 antagonist with an IC50 value of 14 nM. TRPV6 is a non-voltage gated calcium channel that is associated with malignancy and poor prognosis in breast cancer. SOR-C13 has anticancer activity[1]. |
|---|---|
| Related Catalog | |
| In Vivo | SOR-C13 (i.p.; 400,600 or 800 mg/kg; daily; on days 1 to 12) can effectively inhibit the growth of tumor in female NOD/SCID mice with SKOV-3 cell[2]. |
| References |
| Molecular Formula | C72H116N20O19 |
|---|---|
| Molecular Weight | 1565.81 |